NORTHVALE, N.J.--(BUSINESS WIRE)--Elite Pharmaceuticals, Inc. (AMEX: ELI) provided an update on the progress of the Company at the annual shareholders meeting on June 26, 2007. A review of recent key accomplishments and a product pipeline status are provided below.
